Skip to content

Development of personalized home meal medifood and product for patients who undergo anticancer treatment

Development of personalized home meal medifood and product for patients who undergo anticancer treatment

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CRIS
Registry ID
KCT0005438
Enrollment
60
Registered
2020-09-25
Start date
2020-09-16
Completion date
Unknown
Last updated
2020-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(diet) : Divide patients into a control group that only receives nutrition education and self-dishes and a group that provides a diet enhanced with protein, unsaturated fatty acids, and antiox

Sponsors

HANMI NATURAL NUTRITION
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -Only patients between the ages of 20 and under the age of 85. -Patients undergoing or scheduled radiation treatment for digestive cancer. -Karnofsky performance status 70 or higher -Patients who can communicate without any problems in obtaining consent forms related to the test

Exclusion criteria

Exclusion criteria: Exclude patients from any of the following criteria -Pregnant and breastfeeding women -Patients allergic to certain products

Design outcomes

Primary

MeasureTime frame
Nutritional indicator(weight, body cell mass, body fat mass, soft lean mass, PG-SGA);Nutritional intake;Physical measurement

Secondary

MeasureTime frame
Hematologic test(Hemoglobin, Hematocrit, Platelet, WBC, Neutrophil);Biochemical test(Total protein, Albumin, Glucose, BUN, Creatinine, Total bilirubin, AST, ALT)

Countries

Korea, Republic of

Contacts

Public ContactJUNG SEONYU

Yonsei University Health System, Gangnam Severance Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026